Skip to content
10-Q

Quarterly Report

RAPT Therapeutics, Inc.

0000950170-25-104598

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 16.54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.94M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.86M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.84M sh
Capex Q2 2025 · Jun 30, 2025 $83K
Capex Q2 2025 · Jun 30, 2024 $104K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$63.69M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$55.24M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $41.89M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $169.74M
Stockholders Equity Q2 2025 · Jun 30, 2025 $164.41M
Stockholders Equity Q2 2025 · Mar 31, 2025 $177.37M
Stockholders Equity Q2 2025 · Dec 31, 2024 $189.9M
Stockholders Equity Q2 2025 · Jun 30, 2024 $109.22M
Stockholders Equity Q2 2025 · Mar 31, 2024 $130.84M
Stockholders Equity Q2 2025 · Dec 31, 2023 $147.04M
Current Liabilities Q2 2025 · Jun 30, 2025 $13.04M
Current Liabilities Q2 2025 · Dec 31, 2024 $48.35M
Total Liabilities Q2 2025 · Jun 30, 2025 $14M
Total Liabilities Q2 2025 · Dec 31, 2024 $50.42M
Current Assets Q2 2025 · Jun 30, 2025 $172.86M
Current Assets Q2 2025 · Dec 31, 2024 $235.24M
Total Assets Q2 2025 · Jun 30, 2025 $178.41M
Total Assets Q2 2025 · Dec 31, 2024 $240.33M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.65
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.29
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$5.69
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$12.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.65
Eps Basic Q2 2025 · Jun 30, 2025 −$1.29
Eps Basic restated Q2 2025 · Jun 30, 2024 −$5.69
Eps Basic restated Q2 2025 · Jun 30, 2024 −$12.01
Sga Expense Q2 2025 · Jun 30, 2025 $7.2M
Sga Expense Q2 2025 · Jun 30, 2025 $14.42M
Sga Expense Q2 2025 · Jun 30, 2024 $6.69M
Sga Expense Q2 2025 · Jun 30, 2024 $14.43M
Rd Expense Q2 2025 · Jun 30, 2025 $12.34M
Rd Expense Q2 2025 · Jun 30, 2025 $24.38M
Rd Expense Q2 2025 · Jun 30, 2024 $22.64M
Rd Expense Q2 2025 · Jun 30, 2024 $47.42M
Net Income Q2 2025 · Jun 30, 2025 −$17.64M
Net Income Q2 2025 · Jun 30, 2025 −$34.81M
Net Income Q2 2025 · Mar 31, 2025 −$17.17M
Net Income Q2 2025 · Jun 30, 2024 −$27.66M
Net Income Q2 2025 · Jun 30, 2024 −$58.18M
Net Income Q2 2025 · Mar 31, 2024 −$30.52M
Operating Income Q2 2025 · Jun 30, 2025 −$19.54M
Operating Income Q2 2025 · Jun 30, 2025 −$38.8M
Operating Income Q2 2025 · Jun 30, 2024 −$29.33M
Operating Income Q2 2025 · Jun 30, 2024 −$61.85M